CONTROLLED SUBSTANCES-OPIOIDS House SponsorsRep. Dagmara Avelar-La Shawn K. Ford, Aaron M. Ortiz, Delia C. Ramirez, Edgar Gonzalez, Jr., Jaime M. Andrade, Jr., Angelica Guerrero-Cuellar, Eva-Dina Delgado, Elizabeth Hernandez, Barbara Hernandez, Joyce Mason, Emanuel Chris Welch, Stephanie A. Kifowit, Mary E. Flowers, Justin Slaughter, Kathleen Willis and Anthony DeLuca Senate Sponsors(Sen. Emil Jones, III-Christopher Belt) 8/20/2021HousePublic Act . . . . . . . . . 102-0490 720 ILCS 570/401.3 new Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately.House Floor Amendment No. 1 Deletes reference to:720 ILCS 570/401.3 newAdds reference to:720 ILCS 570/311.6 newReplaces everything after the enacting clause. Amends the Illinois Controlled Substances Act. Provides that notwithstanding any other provision of law, a prescription for a substance classified in Schedule II, III, IV, or V must be sent electronically. Provides that notwithstanding any other provision of law, a prescriber shall not be required to issue prescriptions electronically if he or she certifies to the Department of Financial and Professional Regulation that he or she will not issue more than 25 prescriptions during a 12-month period. Prescriptions in both oral and written form for controlled substances shall be included in determining whether the prescriber will reach the limit of 25 prescriptions. Provides that the Department of Financial and Professional Regulation shall adopt rules for the administration of these provisions. Provides that these rules shall provide for the implementation of any such exemption to the requirements under these provisions that the Department of Financial and Professional Regulation may deem appropriate, including the exemption limiting a prescriber from issuing more than 25 prescriptions during a 12-month period. Effective January 1, 2023. 2/19/2021HouseFiled with the Clerk by Rep. Dagmara Avelar 2/22/2021HouseFirst Reading 2/22/2021HouseReferred to Rules Committee 3/16/2021HouseAssigned to Prescription Drug Affordability & Accessibility Committee 3/18/2021HouseAdded Co-Sponsor Rep. Aaron M. Ortiz 3/18/2021HouseAdded Co-Sponsor Rep. Delia C. Ramirez 3/18/2021HouseAdded Co-Sponsor Rep. Edgar Gonzalez, Jr. 3/18/2021HouseAdded Co-Sponsor Rep. Jaime M. Andrade, Jr. 3/18/2021HouseAdded Co-Sponsor Rep. Angelica Guerrero-Cuellar 3/18/2021HouseAdded Co-Sponsor Rep. Eva-Dina Delgado 3/18/2021HouseAdded Co-Sponsor Rep. Elizabeth Hernandez 3/18/2021HouseAdded Co-Sponsor Rep. Barbara Hernandez 3/25/2021HouseAdded Co-Sponsor Rep. Joyce Mason 3/25/2021HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 018-000-000 4/8/2021HousePlaced on Calendar 2nd Reading - Short Debate 4/13/2021HouseSecond Reading - Short Debate 4/13/2021HousePlaced on Calendar Order of 3rd Reading - Short Debate 4/20/2021HouseHouse Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar 4/20/2021HouseHouse Floor Amendment No. 1 Referred to Rules Committee 4/20/2021HouseAdded Co-Sponsor Rep. Emanuel Chris Welch 4/20/2021HouseAdded Co-Sponsor Rep. Stephanie A. Kifowit 4/20/2021HouseAdded Co-Sponsor Rep. Mary E. Flowers 4/21/2021HouseHouse Floor Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee 4/21/2021HouseAdded Co-Sponsor Rep. Justin Slaughter 4/21/2021HouseAdded Co-Sponsor Rep. Kathleen Willis 4/22/2021HouseHouse Floor Amendment No. 1 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 017-002-000 4/22/2021HouseAdded Co-Sponsor Rep. Anthony DeLuca 4/23/2021HouseRecalled to Second Reading - Short Debate 4/23/2021HouseHouse Floor Amendment No. 1 Adopted 4/23/2021HousePlaced on Calendar Order of 3rd Reading - Short Debate 4/23/2021HouseThird Reading - Short Debate - Passed 111-000-000 4/23/2021HouseAdded Chief Co-Sponsor Rep. La Shawn K. Ford 4/27/2021SenateArrive in Senate 4/27/2021SenatePlaced on Calendar Order of First Reading 4/27/2021SenateChief Senate Sponsor Sen. Emil Jones, III 4/27/2021SenateFirst Reading 4/27/2021SenateReferred to Assignments 5/10/2021SenateAssigned to Licensed Activities 5/19/2021SenateDo Pass Licensed Activities; 007-000-000 5/19/2021SenatePlaced on Calendar Order of 2nd Reading May 20, 2021 5/20/2021SenateAdded as Alternate Chief Co-Sponsor Sen. Christopher Belt 5/24/2021SenateSecond Reading 5/24/2021SenatePlaced on Calendar Order of 3rd Reading May 25, 2021 5/27/2021SenatePlaced on Calendar Order of 3rd Reading ** May 28, 2021 5/29/2021SenateThird Reading - Passed; 059-000-000 5/29/2021HousePassed Both Houses 6/25/2021HouseSent to the Governor 8/20/2021HouseGovernor Approved 8/20/2021HouseEffective Date January 1, 2023 8/20/2021HousePublic Act . . . . . . . . . 102-0490